TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Anhui Medical University · First Affiliated Hospital of Anhui Medical University
Abstract
Transforming growth factor-beta1 (TGF-β1), a key member in the TGF-β superfamily, plays a critical role in the development of hepatic fibrosis. Its expression is consistently elevated in affected organs, which correlates with increased extracellular matrix deposition. SMAD proteins have been studied extensively as pivotal intracellular effectors of TGF-β1, acting as transcription factors. In the context of hepatic fibrosis, SMAD3 and SMAD4 are pro-fibrotic, whereas SMAD2 and SMAD7 are protective. Deletion of SMAD3 inhibits type I collagen expression and blocks epithelial-myofibroblast transition. In contrast, disruption of SMAD2 upregulates type I collagen expression. SMAD4 plays an essential role in fibrosis…
Citation impact
- FWCI
- 26.28
- Percentile
- 100%
- References
- 109
Authors
4- FXFengyun XuCorresponding
Anhui Medical University, First Affiliated Hospital of Anhui Medical University
- CLChangwei Liu
Anhui Medical University, First Affiliated Hospital of Anhui Medical University
- DZDandan Zhou
Anhui Medical University, First Affiliated Hospital of Anhui Medical University
- LZLei Zhang
Anhui Medical University, First Affiliated Hospital of Anhui Medical University
Topics & keywords
- SMAD
- Fibrosis
- Transforming growth factor
- Signal transduction
- Extracellular matrix
- Myofibroblast
- Cell biology
- Hepatic fibrosis